US 10,376,601 B2
In-vivo intravascular blood replacing liquid, in-vivo intravascular blood replacing liquid formulation, and prefilled syringe
Koji Nakamura, Hadano (JP); Isao Mori, Chofu (JP); and Masanori Tokida, Fujinomiya (JP)
Assigned to TERUMO KABUSHIKI KAISHA, Shibuya-Ku, Tokyo (JP)
Filed by TERUMO KABUSHIKI KAISHA, Shibuya-ku, Tokyo (JP)
Filed on Sep. 27, 2016, as Appl. No. 15/277,405.
Application 15/277,405 is a continuation of application No. PCT/JP2014/080001, filed on Nov. 12, 2014.
Claims priority of application No. 2014-070571 (JP), filed on Mar. 28, 2014.
Prior Publication US 2017/0014535 A1, Jan. 19, 2017
Int. Cl. A61K 49/22 (2006.01); A61B 1/00 (2006.01); A61K 49/04 (2006.01); A61B 8/12 (2006.01); A61B 8/08 (2006.01); A61M 5/178 (2006.01); A61M 25/00 (2006.01); A61B 8/00 (2006.01); A61M 5/00 (2006.01); A61M 5/31 (2006.01)
CPC A61K 49/226 (2013.01) [A61B 1/00165 (2013.01); A61B 8/12 (2013.01); A61B 8/445 (2013.01); A61B 8/481 (2013.01); A61K 49/0409 (2013.01); A61M 5/178 (2013.01); A61M 25/0097 (2013.01); A61M 5/007 (2013.01); A61M 2005/3104 (2013.01); A61M 2025/0059 (2013.01)] 13 Claims
 
1. An in-vivo intravascular blood replacing liquid comprising:
an aqueous medium unharmful for a living body;
a gelling property imparting substance, unharmful for said living body, which is added to said aqueous medium to impart a gelling property to said blood replacing liquid in an in-vivo intravascular inspection;
said blood replacing liquid having a viscosity of not more than 3 mPa·s when said blood replacing liquid is injected into said blood vessel; and
said gelling property imparting substance being mixtures of glycyrrhizin acids and thiamine chloride hydrochloride.